Intervention StudyNCT03182972
Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria
A study testing Medication reconciliation in people with Intervention Study, run by University of Ibadan at 2 sites in Nigeria.
Trial summary
This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Intervention Study
- What is being tested?
- Medication reconciliation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,000 participants
- Where
- 2 sitesNigeria
- Study dates
- 2 Aug 2016to 30 Apr 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Participant has diabetes and/or hypertension
- Registered pharmacists in the selected institutions
Who cannot join
- Participants that are neither diabetic nor hypertensive
- Unregistered pharmacists in the selected institutions
Trial locations and contacts
2 sites in 1 country.
Nigeria2 sites
University College Hospital
Ibadan, Oyo State, 2334
University of Ilorin Teaching Hospital
Ilorin, Kwara State
About this study
This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered
Read the detailed description
Background information garnering will be done among the pharmacists in the two selected hospitals to collect data on current practice of medication reconciliation. Focus group discussion will be done in the intervention group so as to identify peculiarities of their practice and to provide the best approach to carrying out the intervention. Diabetes and hypertensive patients in medical outpatient clinic will be interviewed in order to assess current practice of medication reconciliation.
Intervention will be channeled towards addressing gaps discovered. University College Hospital, Ibadan, Oyo State will be the intervention group, while University of Ilorin Teaching Hospital, Kwara State will be the control group.
The effect of the intervention will be measured over time to ensure that medication reconciliation is implemented in the selected institutions.
- Conditions
- Intervention Study
- Being tested
- Medication reconciliation
- Keywords
- intervention study, medication reconciliation, pharmacists, Nigeria, Diabetes, Hypertension
- Medical subject headings
- Diabetes Mellitus, Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medication reconciliationOther
Pre-post intervention
| Study group | Role | What they receive |
|---|---|---|
| Intervention arm | Experimental | Seminar presentation will be done using the followings:
1. Power point presentation on the following topics as it relates to medication reconciliation:
1. Communication skill (with patients and also with other members of the healthcare team)
2. Documentation of pharmaceutical care activities
3. Medication history taking
4. Drug therapy problems
5. Medication reconciliation practice
2. Case studies on medication reconciliation
3. Role plays on medication reconciliation Receives: Other: Medication reconciliation |
| Control arm | No intervention | Control group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Medication reconciliation: Percentage unreconciled medications
Percentage unreconciled medications
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jun 2017
- Study start2 Aug 2016
- Primary completion30 Apr 2019
- Study completion30 Apr 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Intervention StudyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- University College Hospital, Ibadan will serve as the intervention group while University of Ilorin Teaching Hospital, Ilorin will serve as the control group.
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 1,000 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Ibadan
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, AKINNIYI AKINBIYI AJE, University of Ibadan
- Investigators
- TITILAYO O FAKEYE, PhD, Study director, University of Ibadan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03182972
- Sponsor's protocol ID
- MR/UCH/FMC/73247
- Status last verified
- Nov 2022
- First submitted
- 8 Jun 2017
- Last updated
- 30 Nov 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 30 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria
- ClinicalTrials.gov ID
- NCT03182972
- Acronym / sponsor ID
- MR/UCH/FMC/73247
- Conditions
- Intervention Study
- Keywords
- intervention study, medication reconciliation, pharmacists, Nigeria, Diabetes, Hypertension
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,000 participants (actual)
- Lead sponsor
- University of IbadanUniversity, hospital or other
- Study start
- 2 Aug 2016 (actual)
- Primary completion
- 30 Apr 2019 (actual)
- Study completion
- 30 Apr 2019 (actual)
- First posted
- 9 Jun 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered
Detailed description
Background information garnering will be done among the pharmacists in the two selected hospitals to collect data on current practice of medication reconciliation. Focus group discussion will be done in the intervention group so as to identify peculiarities of their practice and to provide the best approach to carrying out the intervention. Diabetes and hypertensive patients in medical outpatient clinic will be interviewed in order to assess current practice of medication reconciliation.
Intervention will be channeled towards addressing gaps discovered. University College Hospital, Ibadan, Oyo State will be the intervention group, while University of Ilorin Teaching Hospital, Kwara State will be the control group.
The effect of the intervention will be measured over time to ensure that medication reconciliation is implemented in the selected institutions.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, care provider)
- Number of arms
- 2
- Model description
- University College Hospital, Ibadan will serve as the intervention group while University of Ilorin Teaching Hospital, Ilorin will serve as the control group.
| Arm | Type | Receives |
|---|---|---|
| Intervention arm | Experimental | Other: Medication reconciliationSeminar presentation will be done using the followings: 1. Power point presentation on the following topics as it relates to medication reconciliation: 1. Communication skill (with patients and also with other members of the healthcare team) 2. Documentation of pharmaceutical care activities 3. Medication history taking 4. Drug therapy problems 5. Medication reconciliation practice 2. Case studies on medication reconciliation 3. Role plays on medication reconciliation |
| Control arm | No intervention | –Control group |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Participant has diabetes and/or hypertension
- Registered pharmacists in the selected institutions
Key exclusion criteria (2 listed)
- Participants that are neither diabetic nor hypertensive
- Unregistered pharmacists in the selected institutions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medication reconciliationPre-post intervention | Other | Intervention arm |
Primary outcome
Medication reconciliation: Percentage unreconciled medications
Time frame: 3 months
Percentage unreconciled medications
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Nov 2022.
- Individual participant dataSharing planned: Yes
Related trials for Intervention Study
Not yet recruitingPhase 1
A Study of Phenytoin Mucoadhesive Film for Oral Ulcers in Healthy Volunteers
Oral Ulcer, Oral Mucositis
RecruitingPhase 2
A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
Recurrent Glioblastoma
RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Invasive Mold Infections
RecruitingPhase 1/2
Safety and Efficacy of CG-BM1 in Ischemic Stroke
Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)
Not yet recruiting
New Smoking Cessation Intervention in Primary Care - a Randomized Controlled Trial
Smoking Cessation, Smoking Cessation Counselling
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
TITILAYO O FAKEYE, PhD study director
University of Ibadan
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Medication reconciliation in people with Intervention Study, run by University of Ibadan at 2 sites in Nigeria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Nigeria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Medication reconciliation: Percentage unreconciled medications (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2022.